Cyrus Biotechnology
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1201 2nd Ave Ste 900, Seattle, Washingto...Phone Number
(206) 258-6561Website
www.cyrusbio.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Cyrus Biotechnology
Cyrus Bio is a computationally-driven discovery company that focuses on naturally existing proteins with the potential to be developed into superior therapeutics. They employ computational modeling and deep mutagenesis to create biologics, with a proven platform that includes over 30 discovery programs in collaboration with partners. Their lead programs target severe autoimmune diseases and therapeutic immuno cytokines, addressing significant clinical markets. Cyrus Bio's innovative approach integrates novel algorithms and sophisticated laboratory methods to enhance protein design and efficacy.Explore more
Cyrus Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cyrus Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cyrus Biotechnology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cyrus Biotechnology
Cyrus Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cyrus Biotechnology is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cyrus Biotechnology launches new products
Funding: Get notified immidiatlly once Cyrus Biotechnology has new funding data
Check if Cyrus Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cyrus Biotechnology recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Cyrus Biotechnology
Compare insights from companies similar to Cyrus Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cyrus Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cyrus Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cyrus Biotechnology.
Cyrus Biotechnology financials insights
Gather financial insights about Cyrus Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$850K
2016
Debt
$535K
2017
Private Equity
$1M
Series A
$8M
2020
Debt
$350K
2021
Series B
$18M
Cyrus Biotechnology Tech Stack
A closer look at the technologies used by Cyrus Biotechnology
See more technologies
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Funding
Project
Spending/Investment, Funding
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Facilities Relocation / Expansion
Cyrus Biotechnology is planning to move offices in August 2024. The move will impact approximately 15 employees at the existing office located at 3005 1St Ave, Suite#203, Seattle, WA.
Facilities Relocation/Expansion
Event
Events
Cyrus Biotechnology News & Media
Cyrus Biotechnology Announces Potent in vivo Redosability of an Engineered IdeS Protease for IgG-driven Autoimmune Disease, Demonstrating No Anti-drug Antibodies
SEATTLE--(BUSINESS WIRE)--Cyrus Biotechnology announces potent in vivo redosability of an engineered IdeS protease for IgG-driven autoimmune disease.Cyrus Biotechnology to Present its Protein Engineering Capability, Immunogenicity Risk Mitigation, and Best-in-Class IgG Protease Candidate at Hit ID Summit
SEATTLE--(BUSINESS WIRE)--Presentation by CSO Dr. Yifan Song includes data demonstrating Cyrus’s hybrid AI/screening platform in risk mitigation of protein therapeutics.Cyrus Biotechnology Congratulates David Baker, 2024 Nobel Laureate in Chemistry and Cyrus Co-Founder
SEATTLE--(BUSINESS WIRE)--Baker, who co-founded Cyrus, was the first to make high accuracy protein structure predictions and design a novel protein in a computer.Cyrus Biotechnology Spins out Levitate Bio, a Protein AI, Bioinformatics, and Rosetta Service Provider, to Bring Automated, Customized AI Solutions to Biopharma Drug Discovery
SEATTLE--(BUSINESS WIRE)--A static set of software products doesn't fit the needs of the pharma industry, Levitate will offer a full stack of customized software and services
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cyrus Biotechnology
Sign Up For FreeTo access detailed company insights
Cyrus Bio is a computationally-driven discovery company that focuses on naturally existing proteins with the potential to be developed into superior therapeutics. They employ computational modeling and deep mutagenesis to create biologics, with a proven platform that includes over 30 discovery programs in collaboration with partners. Their lead pro... Read More
